UBS Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.2M | Buy |
595,455
+306,808
| +106% | +$32M | 0.01% | 1048 |
|
|
2025
Q1 | $33.7M | Buy |
288,647
+141,300
| +96% | +$16.5M | 0.01% | 1444 |
|
|
2024
Q4 | $12.5M | Buy |
147,347
+99,585
| +209% | +$8.43M | ﹤0.01% | 2152 |
|
|
2024
Q3 | $4.29M | Buy |
47,762
+8,058
| +20% | +$724K | ﹤0.01% | 2404 |
|
|
2024
Q2 | $3.2M | Sell |
39,704
-21,616
| -35% | -$1.74M | ﹤0.01% | 2458 |
|
|
2024
Q1 | $4.89M | Buy |
61,320
+21,195
| +53% | +$1.69M | ﹤0.01% | 2211 |
|
|
2023
Q4 | $3.19M | Buy |
40,125
+7,341
| +22% | +$584K | ﹤0.01% | 2415 |
|
|
2023
Q3 | $2.29M | Buy |
32,784
+18,205
| +125% | +$1.27M | ﹤0.01% | 2441 |
|
|
2023
Q2 | $1.05M | Sell |
14,579
-1,692
| -10% | -$122K | ﹤0.01% | 3263 |
|
|
2023
Q1 | $1M | Buy |
16,271
+3,214
| +25% | +$198K | ﹤0.01% | 3171 |
|
|
2022
Q4 | $1.01M | Sell |
13,057
-5,244
| -29% | -$404K | ﹤0.01% | 3131 |
|
|
2022
Q3 | $817K | Buy |
18,301
+3,914
| +27% | +$175K | ﹤0.01% | 3001 |
|
|
2022
Q2 | $551K | Sell |
14,387
-2,004
| -12% | -$76.8K | ﹤0.01% | 3291 |
|
|
2022
Q1 | $678K | Buy |
16,391
+13,357
| +440% | +$553K | ﹤0.01% | 3548 |
|
|
2021
Q4 | $114K | Sell |
3,034
-6,312
| -68% | -$237K | ﹤0.01% | 5124 |
|
|
2021
Q3 | $308K | Sell |
9,346
-1,836
| -16% | -$60.5K | ﹤0.01% | 4004 |
|
|
2021
Q2 | $754K | Buy |
11,182
+1,738
| +18% | +$117K | ﹤0.01% | 3459 |
|
|
2021
Q1 | $535K | Buy |
9,444
+530
| +6% | +$30K | ﹤0.01% | 3878 |
|
|
2020
Q4 | $726K | Sell |
8,914
-4,539
| -34% | -$370K | ﹤0.01% | 3384 |
|
|
2020
Q3 | $959K | Sell |
13,453
-3,712
| -22% | -$265K | ﹤0.01% | 2951 |
|
|
2020
Q2 | $1.41M | Sell |
17,165
-3,792
| -18% | -$312K | ﹤0.01% | 2549 |
|
|
2020
Q1 | $1.23M | Sell |
20,957
-23,463
| -53% | -$1.38M | ﹤0.01% | 2512 |
|
|
2019
Q4 | $4.59M | Sell |
44,420
-1,322
| -3% | -$137K | ﹤0.01% | 2059 |
|
|
2019
Q3 | $926K | Buy |
45,742
+42,377
| +1,259% | +$858K | ﹤0.01% | 3250 |
|
|
2019
Q2 | $86K | Buy |
3,365
+1,530
| +83% | +$39.1K | ﹤0.01% | 4637 |
|
|
2019
Q1 | $26K | Buy |
+1,835
| New | +$26K | ﹤0.01% | 5231 |
|
|
2018
Q3 | – | Sell |
-279
| Closed | -$1K | – | 7017 |
|
|
2018
Q2 | $1K | Buy |
+279
| New | +$1K | ﹤0.01% | 6869 |
|
|
2017
Q4 | – | Sell |
-240
| Closed | -$1K | – | 6836 |
|
|
2017
Q3 | $1K | Sell |
240
-1,142
| -83% | -$4.76K | ﹤0.01% | 6629 |
|
|
2017
Q2 | $8K | Buy |
1,382
+1,113
| +414% | +$6.44K | ﹤0.01% | 5948 |
|
|
2017
Q1 | $1K | Sell |
269
-1,481
| -85% | -$5.51K | ﹤0.01% | 6466 |
|
|
2016
Q4 | $12K | Buy |
+1,750
| New | +$12K | ﹤0.01% | 5847 |
|
|
2016
Q3 | – | Sell |
-937
| Closed | -$7K | – | 6688 |
|
|
2016
Q2 | $7K | Sell |
937
-11,018
| -92% | -$82.3K | ﹤0.01% | 6060 |
|
|
2016
Q1 | $103K | Buy |
+11,955
| New | +$103K | ﹤0.01% | 4213 |
|